Provisional Agenda

Friday 19th September, 2025a

Registration

Welcome
Vickie Lee, Imperial College Healthcare NHS Trust and Mario Salvi, President of EUGOGO

Pathogenesis

Thyroid Autoimmunity & TED
Colin Dayan, University of Cardiff

TED Immunology
Sijie Fang

Orbital Fibroblast Biology
Gina-Eva Görtz, University Hospital Essen

Animal Models
Anja Eckstein, University Duisburg Essen

Proteomics, Lipidomics
TBC

TED and the Microbiome
Marian Ludgate, Cardiff University School of Medicine

Panel Discussion

Coffee Break

Thyroid Management and Risk Factors

Thyroid Management in a Changing Landscape
Chrysoula Dosiou, Stanford University School of Medicine

TED Biomarkers
Hans Olav Ueland, Haukeland University Hospital

Definitive Treatment options: Radioiodine vs. Thyroidectomy
Karim Meeran, Imperial College London

Managing Risk Factors
Milos Zarkovic, University of Belgrade

Total Ablation
Michele Marinò, University of Pisa

Panel Discussion

Industry Symposium
Sponsored by Amgen

Lunch and Exhibition Viewing

TED Examination

Clinical Assessment
Michael Kazim

Imaging
Kunwar Bhatia

AI Assessment
Kyubo Shin, Thyroscope Inc.

Ocular Surface in TED
Andrea Kossler, Stanford University

Ocular Hypertension in TED
Nicole Fichter, ADMEDICO orbital centre

Inflammation or Progression of TED
Peter Dolman, University of British Columbia

Panel Discussion

Coffee Break

Diverse Manifestations

Hypothyroid & Euthyroid TED
Maria-Cristina Burlacu, Cliniques Universitaires Saint-Luc

Ethnic Variations in TED Presentations
Gangadhara Sundar, National University Hospital

Paediatric TED
Peerooz Saeed, Amsterdam University Medical Center

Phenotypes of TED
Jimmy Uddin

TED Mimickers
Vickie Lee, Imperial College Healthcare NHS Trust

Panel Discussion

Close

Networking Reception

 

a

Saturday 20th September, 2025

Registration

Treatments

Statins & Selenium
Michele Marinò, University of Pisa

Sirolimus
Kelvin Chong, The Chinese University of Hong Kong

Immunomodulation Options - Should Steroids Still Have a Role?
Mario Salvi, President of EUGOGO

When should we use Rituximab ?
Mario Salvi, President of EUGOGO and Marius Stan, Mayo Clinic

Local Treatments (Triamcinolone / Botulinum /5 FU)
Onur Konuk, Gazi University Medical School

Orbital Radiotherapy
Peter Dolman, University of British Columbia

Panel Discussion

Coffee Break

Therapies with Special Targets

Tocilizumab – can you please move this to Therapies with special  targets
Ilaria Müller, University of Milan

Teprotumumab: A Review of Efficacy & Longevity
Andrea Kossler, Stanford University

IGF-1R Antagonists
Suzanne Freitag, Harvard Medical School

FcRn Inhibitors
George Kahaly

Autoantibodies to the TSH receptor – mechanisms of action and new therapeutics
Bernard Rees Smith, FIRS Laboratories

Adverse Events of the New Targeted Therapies
Marius Stan, Mayo Clinic

Relapse after Targeted Therapies
Chrysoula Dosiou, Stanford University School of Medicine

Panel Discussion

Industry Symposium
Sponsored by Viridian Therapeutics, Inc.

Lunch and Exhibition Viewing

Panel Discussion: Future Combination Therapies – Q & A

Surgical Therapies: Debates pre and post Targeted therapy

DON Treatment – Conventional Challenges
Nicola Curro

DON Treatment – New Paradigm
Juliette Abeillon, Hospices Civils de Lyon

Orbital Decompression (Conventional Challenges)
Marta Perez Lopez, Hospital Universitario y Politécnico La Fe

Orbital Decompression (Post-Teprotumumab)
Michael Kazim

Strabismus Surgery – Aim for Symmetry
Anja Eckstein, University Duisburg Essen

Strabismus Surgery Post-Teprotumumab
Madhura Tamhankar, University of Pennsylvania

Eyelid Surgery in TED
Diego Strianese

Surgical Timing Before & After Teprotumumab
Andrea Kossler, Stanford University

Panel Discussion

Case Discussions with Experts
Michael Schittowski, University Medical Center
TBC Others

Gala Dinner – Royal Geographical Society

a

Sunday 21st September, 2025

Registration

Measuring Outcomes in TED interventions
Vickie Lee, Imperial College Healthcare NHS Trust

New Quality of Life Assessments
Katharina Ponto, Mainz University Hospital

Global TED Forum Workshop
Breakout Groups for Discussion

Unmet Needs & Ideal Outcome Measures (Joint Groups with Industry)

Future Research Projects

Action Points

Coffee Break

Guidelines, EMA, Questionnaire

New Guidelines
Tomasz Bednarczuk, Medical University of Warsaw

Global Registry
Anja Eckstein, University Duisburg Essen

Global TED Forum Questionnaire Summary

Conference Closes